Have your own idea? Try our Stock Screener
Canadian (TSX) Clinical Research and Equipment Industry Analysis
UpdatedNov 13, 2024
DataAggregated Company Financials
Companies2
- 7D0%
- 3M-16.6%
- 1Y83.6%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 3.1%, driven by a pullback from Telescope Innovations of 7.3%. On the other hand Innovotech is actually up 15%. In the past year, the industry has gained 84%.
Industry Valuation and Performance
Has the Canadian Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 13 Nov 2024 | CA$26.3m | CA$5.1m | -CA$1,418,028.00 | n/a | -18.5x | 5.1x |
| Fri, 11 Oct 2024 | CA$29.2m | CA$5.1m | -CA$1,418,028.00 | n/a | -20.6x | 5.7x |
| Sun, 08 Sep 2024 | CA$55.5m | CA$5.1m | -CA$4,554,454.00 | n/a | -12.2x | 10.8x |
| Tue, 06 Aug 2024 | CA$59.8m | CA$5.1m | -CA$4,366,737.00 | n/a | -13.7x | 11.6x |
| Thu, 04 Jul 2024 | CA$58.9m | CA$4.9m | -CA$4,098,591.00 | n/a | -14.4x | 12x |
| Sat, 01 Jun 2024 | CA$56.7m | CA$4.9m | -CA$3,824,483.00 | n/a | -14.8x | 11.5x |
| Mon, 29 Apr 2024 | CA$64.1m | CA$4.9m | -CA$3,805,287.00 | n/a | -16.8x | 13.2x |
| Wed, 27 Mar 2024 | CA$68.2m | CA$4.9m | -CA$2,943,594.00 | n/a | -23.2x | 13.9x |
| Fri, 23 Feb 2024 | CA$53.0m | CA$4.9m | -CA$1,290,813.00 | n/a | -41x | 10.8x |
| Sun, 21 Jan 2024 | CA$208.3m | CA$23.4m | -CA$24,636,048.00 | n/a | -8.5x | 8.9x |
| Tue, 19 Dec 2023 | CA$196.4m | CA$23.5m | -CA$24,854,730.00 | n/a | -7.9x | 8.4x |
| Thu, 16 Nov 2023 | CA$196.8m | CA$23.7m | -CA$24,695,492.00 | n/a | -8x | 8.3x |
| Sat, 14 Oct 2023 | CA$195.8m | CA$23.7m | -CA$24,695,492.00 | n/a | -7.9x | 8.3x |
| Mon, 11 Sep 2023 | CA$196.6m | CA$23.7m | -CA$24,644,997.00 | n/a | -8x | 8.3x |
| Wed, 09 Aug 2023 | CA$201.6m | CA$23.5m | -CA$24,780,404.00 | n/a | -8.1x | 8.6x |
| Fri, 07 Jul 2023 | CA$201.7m | CA$23.5m | -CA$24,780,404.00 | n/a | -8.1x | 8.6x |
| Sun, 04 Jun 2023 | CA$174.0m | CA$22.5m | -CA$25,042,100.00 | n/a | -6.9x | 7.7x |
| Tue, 02 May 2023 | CA$185.4m | CA$23.6m | -CA$27,033,759.00 | n/a | -6.9x | 7.9x |
| Thu, 30 Mar 2023 | CA$188.9m | CA$23.0m | -CA$29,977,765.00 | 39x | -6.3x | 8.2x |
| Sat, 25 Feb 2023 | CA$192.4m | CA$23.0m | -CA$29,977,765.00 | 39x | -6.4x | 8.4x |
| Mon, 23 Jan 2023 | CA$193.5m | CA$22.4m | -CA$30,499,829.00 | 39x | -6.3x | 8.6x |
| Wed, 21 Dec 2022 | CA$190.2m | CA$21.8m | -CA$30,309,915.00 | 35.1x | -6.3x | 8.7x |
| Fri, 18 Nov 2022 | CA$194.5m | CA$21.8m | -CA$30,309,915.00 | 39.1x | -6.4x | 8.9x |
| Sun, 16 Oct 2022 | CA$186.9m | CA$21.7m | -CA$30,373,079.00 | 72.1x | -6.2x | 8.6x |
| Tue, 13 Sep 2022 | CA$207.5m | CA$21.6m | -CA$24,222,079.00 | 78.8x | -8.6x | 9.6x |
| Thu, 11 Aug 2022 | CA$187.2m | CA$21.9m | -CA$23,995,882.00 | 20.5x | -7.8x | 8.6x |
| Sat, 09 Jul 2022 | CA$165.0m | CA$21.5m | -CA$26,689,749.00 | 19.9x | -6.2x | 7.7x |
| Mon, 06 Jun 2022 | CA$207.3m | CA$21.5m | -CA$26,689,749.00 | 19.3x | -7.8x | 9.6x |
| Wed, 04 May 2022 | CA$230.1m | CA$21.5m | -CA$26,635,227.00 | 18.6x | -8.6x | 10.7x |
| Fri, 01 Apr 2022 | CA$187.3m | CA$21.6m | -CA$23,635,914.00 | 25.9x | -7.9x | 8.7x |
| Sun, 27 Feb 2022 | CA$179.7m | CA$21.3m | -CA$21,103,914.00 | 25.9x | -8.5x | 8.4x |
| Tue, 25 Jan 2022 | CA$212.1m | CA$20.9m | -CA$20,076,847.00 | 24.6x | -10.6x | 10.1x |
| Thu, 23 Dec 2021 | CA$244.2m | CA$20.9m | -CA$19,542,109.00 | 27.3x | -12.5x | 11.7x |
| Sat, 20 Nov 2021 | CA$254.5m | CA$21.0m | -CA$14,997,109.00 | 25.2x | -17x | 12.1x |
Price to Earnings Ratio
-17x
Current Industry PE
- There are only 2 companies in the Canadian Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 37% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Comparison
How does Canadian Clinical Research and Equipment compare with similar industries?
| CA Market | 0.63% | |
| Healthcare | -11.46% | |
| Life Sciences | 0% | |
| Clinical Research and Equipment | 0% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SONA Sona Nanotech | CA$0.28 | 5.8% +CA$1.7m | 27.9% | PE-10.2x |